Access the full text.
Sign up today, get DeepDyve free for 14 days.
Mohamed Omar, James Wilson, Tamara Cox (2001)
Rhabdomyolysis and HMG-CoA Reductase InhibitorsAnnals of Pharmacotherapy, 35
B. Bégaud (2000)
[Criteria of imputability in accidents of drug-induced origin].La Revue du praticien, 50 16
L. Dayer-Berenson (1994)
Rhabdomyolysis: a comprehensive guide.ANNA journal, 21 1
(1984)
Les atteintes musculaires d’origine médicamenteuse
(1993)
Estimation of under-reporting. Methodological approaches in pharmacoepidemiology: application to spontaneous reporting ARME-P
P. Daniel, O. Pratt, E. Spargo (1977)
THE METABOLIC HOMŒOSTATIC ROLE OF MUSCLE AND ITS FUNCTION AS A STORE OF PROTEINThe Lancet, 310
(1990)
Liver injuries: a prospective study (abstract)
G. Serratrice, C. Desnuelle, D. Cros (1984)
[Muscular involvement of drug origin].Therapie, 39 6
B. Bannwarth (2002)
Drug-induced myopathiesExpert Opinion on Drug Safety, 1
C. Mora, M. Rodríguez, J. Navarro (2001)
Cerivastatin-induced rhabdomyolysis in a renal transplant on cyclosporin.Transplantation, 72 3
M. Egan, Anissa Dargham, Darrelll Kirch, R. Wyatt (1993)
Serum Creatine Phosphokinase Elevations in Patients with Tardive DyskinesiaBritish Journal of Psychiatry, 162
M. Dalakas, I. Illa, G. Pezeshkpour, J. Laukaitis, Bruce Cohen, J. Griffin (1990)
Mitochondrial myopathy caused by long-term zidovudine therapy.The New England journal of medicine, 322 16
J. Gutierrez, J. Hidalgo, P. Blesa, E. Ruiz, F. Mora (2003)
[Pharmacological interactions of statins].Atencion primaria, 31 4
Georg Northoff, J. Wenke, B. Pflug (1996)
Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patientsPsychological Medicine, 26
R. Wortmann (2002)
Lipid-lowering agents and myopathyCurrent Opinion in Rheumatology, 14
Memduh Ucar, T. Mjörndal, R. Dahlqvist (2000)
HMG-CoA Reductase Inhibitors and MyotoxicityDrug Safety, 22
R. Pasternak, Sidney Smith, C. Bairey-Merz, S. Grundy, J. Cleeman, C. Lenfant (2002)
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.Circulation, 106 8
P. Tubert, B. Bégaud, J. Péré, F. Haramburu, J. Lellouch (1992)
Power and weakness of spontaneous reporting: a probabilistic approach.Journal of clinical epidemiology, 45 3
J. Sieb, T. Gillessen (2003)
Iatrogenic and toxic myopathiesMuscle & Nerve, 27
I. Hamilton‐Craig (2001)
Statin‐associated myopathyMedical Journal of Australia, 175
T. Azaz-Livshits, M. Levy, B. Sadan, M. Shalit, G. Geisslinger, K. Brune (1998)
Computerized surveillance of adverse drug reactions in hospital: pilot study
P. Thürmann (2001)
Methods and Systems to Detect Adverse Drug Reactions in HospitalsDrug Safety, 24
Haleh Bagheri, F. Michel, M. Lapeyre-Mestre, E. Lagier, J. Cambus, P. Valdiguie, J. Montastruc (2001)
Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals.British journal of clinical pharmacology, 50 5
P. Gabow, W. Kaehny, S. Kelleher (1982)
The Spectrum of RhabdomyolysisMedicine, 61
W. Lui (1979)
Phenothiazine-induced dystonia associated with an increase in serum creatine phosphokinase.Archives of Disease in Childhood, 54
J. Aviña-Zubieta, E. Johnson, M. Suarez‐Almazor, A. Russell (1995)
Incidence of myopathy in patients treated with antimalarials. A report of three cases and a review of the literature.British journal of rheumatology, 34 2
T. Azaz-Livshits, M. Levy, B. Sadan, M. Shalit, G. Geisslinger, K. Brune (1998)
Computerized survelliance of adverse drug reactions in hospital: pilot study.British journal of clinical pharmacology, 45 3
M. Levy, T. Azaz-Livshits, B. Sadan, M. Shalit, Gerd Geisslinger, Kay Brune (1999)
Computerized surveillance of adverse drug reactions in hospital: ImplementationEuropean Journal of Clinical Pharmacology, 54
I Edwards, Jeffrey Aronson (2000)
Adverse drug reactions: definitions, diagnosis, and managementThe Lancet, 356
P. Cacoub, A. Sbaï, P. Azizi, M. Gatfossé, P. Godeau, J. Piette (1999)
[Polymyositis induced by tiopronine].Presse medicale, 28 17
F. Charatan (2001)
Exercise and diet reduce risk of diabetes, US study showsBMJ : British Medical Journal, 323
J. Blanco, M. Zabalza, J. Salcedo, L. Echeverría, Ana García, M. Vallejo (2002)
Rhabdomyolysis of Infectious and Noninfectious CausesSouthern Medical Journal, 95
(2002)
Incidence and determinants of CK and liver function measurements in patients using statins
D. Gaist, Luis Rodríguez, C. Huerta, J. Hallas, S. Sindrup (2001)
Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up StudyEpidemiology, 12
I. Tegeder, M. Levy, U. Muth‐Selbach, R. Oelkers, F. Neumann, H. Dormann, T. Azaz-Livshits, M. Criegee-Rieck, H. Schneider, E. Hahn, K. Brune, G. Geisslinger (1999)
Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.British journal of clinical pharmacology, 47 5
M. Evans, A. Rees (2002)
Effects of HMG-CoA Reductase Inhibitors on Skeletal MuscleDrug Safety, 25
P. O'hara, C. Neutel (2002)
Maintaining confidentiality in research dataPharmacoepidemiology and Drug Safety, 11
L. Teichholz (2003)
Statin-associated myopathy with normal creatine kinase levels.Annals of internal medicine, 138 12
The results of this survey underline the importance to take into account drug hypothesis in muscular injuries diagnosis.
European Journal of Clinical Pharmacology – Springer Journals
Published: Apr 28, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.